A multicenter study sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) demonstrated a 1% incidence of clinically relevant copy number variants in fetuses with normal karyotypes independent of indication for testing and a 6% incidence in fetuses with structural abnormalities (2).